[18F]PI-2620 Phase 3 Histopathological Study

Summary

This study is an open-label, multi-center, non-randomized pivotal Phase 3 study to assess the efficacy and safety of PET imaging with \[18F\]PI-2620 for detection of tau deposition in subjects with Alzheimer's disease (AD) and controls during lifetime when compared to histopathology obtained after death and completion of brain autopsy.

Timeline

Start

2022-12-01

Primary completion

2027-06

Completion

2027-06

Drugs

Indications